A pharmacokinetic-pharmacodynamic/toxicodynamic model framework for PARP inhibitor combination therapy with DNA-damaging chemotherapeutics

Cancer Chemotherapy and Pharmacology 2026

View at publisher

Authors: Li Chen, Ronald W Bucher, Derek W. Bartlett

DOI: 10.1007/s00280-025-04862-w

Cited by: 0

References: 51

Fields of Study & Subjects

PARP inhibition in cancer therapy Mathematical Biology Tumor Growth Statistical Methods in Clinical Trials

References 51